Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
320 |
|
| Actual shortage: | 9 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 305 (95%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 54 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ADVAIR 125 | 125MCG 25MCG | AEROSOL, METERED DOSE | Resolved | 2021-12-14 | 2022-01-19 | 151138 |
| ADVAIR 125 | 125MCG 25MCG | AEROSOL, METERED DOSE | Resolved | 2022-04-08 | 2022-05-18 | 158376 |
| ADVAIR 250 | 250MCG 25MCG | AEROSOL, METERED DOSE | Resolved | 2021-12-10 | 2022-01-05 | 150921 |
| ADVAIR 250 | 250MCG 25MCG | AEROSOL, METERED DOSE | Resolved | 2022-08-10 | 2022-08-31 | 166414 |
| TOCTINO | 10MG | CAPSULE | Resolved | 2019-01-18 | 2019-02-05 | 72897 |
| TOCTINO | 30MG | CAPSULE | Resolved | 2021-02-19 | 2021-03-11 | 134400 |
| ZEJULA | 100MG | CAPSULE | Resolved | 2023-07-28 | 2023-09-28 | 200374 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2018-12-12 | 2019-02-22 | 69396 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2019-05-17 | 2019-08-16 | 84337 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2020-02-21 | 2020-03-26 | 106829 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2021-11-26 | 2022-03-02 | 149987 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Actual shortage | 2023-11-23 | 2024-01-24 | 211335 |
| STIEVA-A | 0.05% | CREAM | Resolved | 2019-11-08 | 2019-12-06 | 98223 |
| STIEVA-A | 0.05% | CREAM | Resolved | 2020-05-08 | 2020-07-15 | 114294 |
| STIEVA-A | 0.05% | CREAM | Resolved | 2021-11-17 | 2022-01-05 | 149516 |
| STIEVA-A | 0.05% | CREAM | Resolved | 2022-09-23 | 2022-11-09 | 170091 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2020-05-08 | 2020-06-24 | 114291 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2020-07-10 | 2020-09-02 | 119953 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2021-03-12 | 2021-03-24 | 135587 |
| STIEVA-A | 0.025% | CREAM | Resolved | 2021-05-28 | 2021-06-03 | 140091 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| REQUIP | 5MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22603 |
| ZANTAC | 150MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22611 |
| ZANTAC | 300MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22614 |
| AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
| AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
| AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
| AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |
| HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |
| CLAVULIN 500 F TAB | 125MG 500MG | TABLET | Discontinued | 2024-02-02 | 2024-02-02 | 218240 |
| PAXIL TAB 10MG | 10MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224405 |
| PAXIL TAB 30MG | 30MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224430 |
| MESASAL | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2017-03-17 | 2017-03-24 | 3333 |